Shopping cart is empty.

Print this page

Wheatgrass Research

Wheatgrass has remarkable healing properties, many examples of which can be found on this website. I believe these effects are most likely due to the influence of wheatgrass bioactives on gene expression. Time will tell.
Your comments are welcome. Thank you.
Dr. Chris Reynolds. M.B.,B.S.
 

Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients.

Babosa M., Borgulya G., Hauser P., Hidvégi M., Müller J., Paksy A., Schuler D., Szabó E., Fekete G., Garami M. 2004. J. Ped. Hem./Onc. Vol26:10:631-635

PURPOSE: An open-label, matched-pair (by diagnosis, stage of disease, age, and gender) pilot clinical trial was conducted to test whether the combined administration of the medical nutriment MSC (Avemar) with cytotoxic drugs and the continued administration of MSC on its own help to reduce the incidence of treatment-related febrile neutropenia in children with solid cancers compared with the same treatments without MSC.

METHODS: Between December 1998 and May 2002, 22 patients (11 pairs) were enrolled in this study. At baseline, the staging of the tumors was the same in each pair (mostly pTNM = T2N0M0), with the exception of two cases in which patients in the MSC group had worse prognoses (metastasis at baseline). There were no significant differences in the average age of the patients, the length of treatment time (MSC) or follow-up, the number of patients with central venous catheters, the number of chemotherapy cycles, the frequency of preventive counterneutropenic interventions, or the type and dosage of antibiotic and antipyretic therapy used in the two groups.

RESULTS: During the treatment (follow-up) period, there was no progression of the malignant disease, whereas at end-point the number and frequency of febrile neutropenic events significantly differed between the two groups: 30 febrile neutropenic episodes (24.8%) in the MSC group versus 46 (43.4%) in the control group (Wilcoxon signed rank test, P < 0.05).

CONCLUSIONS: The continuous supplementation of anticancer therapies with the medical nutriment MSC helps to reduce the incidence of treatment-related febrile neutropenia in children with solid cancers.

Original publication (pdf)
Reproduced by kind permission of Biropharma Kft.

Dr. Chris Reynolds | Sunday, August 15, 2010 | Comments (0) | Permalink
RSS Subscribe
SuMoTuWeThFrSa
   1234
567891011
12131415161718
19202122232425
26272829   
Archive
Topics
Tags

Refer a friend






Captcha Image

Can Dr Chris help you?

Ask Dr. Chris
Conditions
Success Stories
Healing Tips
Forums
FAQ
Research
About Wheatgrass
Dr. Chris' Articles
Introduce A Friend
Links
Free Newsletter
Return to Resellers' Catalogue
Update your details